Rapid Diagnostic Testing for Influenza Market Report

Global and Region Rapid Diagnostic Testing for Influenza Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：187
  • REPORT CODE：GMM999862
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Rapid Diagnostic Testing for Influenza companies are mainly from North America; the industry concentrate rate is relatively high. The top three companies are BD, BioMerieux and Abbott with the revenue market share of 24.71%, 24.08% and 13.12% in 2019.

    The report details the trend, potential and market size of Rapid Diagnostic Testing for Influenza market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Rapid Diagnostic Testing for Influenzamarket, defines the market attractiveness level of Rapid Diagnostic Testing for Influenza market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Rapid Diagnostic Testing for Influenza industry, describes the types of Rapid Diagnostic Testing for Influenza market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rapid Diagnostic Testing for Influenza market and the development prospects and opportunities of Rapid Diagnostic Testing for Influenza industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rapid Diagnostic Testing for Influenza market in Chapter 13.

    By Player:

    • BD

    • BioMerieux

    • Abbott

    • Sekisui Diagnostics

    • Princeton BioMeditech Corporation

    • Quidel

    • Response Biomedical

    • Meridian Bioscience

    • Thermo Fisher Scientific

    • SA Scientific

    By Type:

    • Type A Flu

    • Type B Flu

    By End-User:

    • Point-of-care Testing Hospitals

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Rapid Diagnostic Testing for Influenza Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Rapid Diagnostic Testing for Influenza Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Rapid Diagnostic Testing for Influenza Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Rapid Diagnostic Testing for Influenza Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Rapid Diagnostic Testing for Influenza Market Analysis and Outlook to 2022

    • 7.1 Global Rapid Diagnostic Testing for Influenza Consumption (2017-2022)

    • 7.2 United States Rapid Diagnostic Testing for Influenza Consumption (2017-2022)

    • 7.3 Europe Rapid Diagnostic Testing for Influenza Consumption (2017-2022)

    • 7.4 China Rapid Diagnostic Testing for Influenza Consumption (2017-2022)

    • 7.5 Japan Rapid Diagnostic Testing for Influenza Consumption (2017-2022)

    • 7.6 India Rapid Diagnostic Testing for Influenza Consumption (2017-2022)

    • 7.7 South Korea Rapid Diagnostic Testing for Influenza Consumption (2017-2022)

    8 Region and Country-wise Rapid Diagnostic Testing for Influenza Market Analysis and Outlook to 2028

    • 8.1 Global Rapid Diagnostic Testing for Influenza Consumption Forecast (2022-2028)

    • 8.2 United States Rapid Diagnostic Testing for Influenza Consumption Forecast (2022-2028)

    • 8.3 Europe Rapid Diagnostic Testing for Influenza Consumption Forecast (2022-2028)

    • 8.4 China Rapid Diagnostic Testing for Influenza Consumption Forecast (2022-2028)

    • 8.5 Japan Rapid Diagnostic Testing for Influenza Consumption Forecast (2022-2028)

    • 8.6 India Rapid Diagnostic Testing for Influenza Consumption Forecast (2022-2028)

    • 8.7 South Korea Rapid Diagnostic Testing for Influenza Consumption Forecast (2022-2028)

    9 Global Rapid Diagnostic Testing for Influenza Market Outlook by Types and Applications to 2022

    • 9.1 Global Rapid Diagnostic Testing for Influenza Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Type A Flu Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Type B Flu Consumption and Growth Rate (2017-2022)

    • 9.2 Global Rapid Diagnostic Testing for Influenza Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Point-of-care Testing Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Rapid Diagnostic Testing for Influenza Market Outlook by Types and Applications to 2028

    • 10.1 Global Rapid Diagnostic Testing for Influenza Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Type A Flu Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Type B Flu Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Rapid Diagnostic Testing for Influenza Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Point-of-care Testing Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Rapid Diagnostic Testing for Influenza Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Rapid Diagnostic Testing for Influenza Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Rapid Diagnostic Testing for Influenza Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Rapid Diagnostic Testing for Influenza Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Rapid Diagnostic Testing for Influenza Market Competitive Analysis

    • 14.1 BD

      • 14.1.1 BD Company Details

      • 14.1.2 BD Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 BD Rapid Diagnostic Testing for Influenza Product and Service

    • 14.2 BioMerieux

      • 14.2.1 BioMerieux Company Details

      • 14.2.2 BioMerieux Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 BioMerieux Rapid Diagnostic Testing for Influenza Product and Service

    • 14.3 Abbott

      • 14.3.1 Abbott Company Details

      • 14.3.2 Abbott Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Abbott Rapid Diagnostic Testing for Influenza Product and Service

    • 14.4 Sekisui Diagnostics

      • 14.4.1 Sekisui Diagnostics Company Details

      • 14.4.2 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product and Service

    • 14.5 Princeton BioMeditech Corporation

      • 14.5.1 Princeton BioMeditech Corporation Company Details

      • 14.5.2 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product and Service

    • 14.6 Quidel

      • 14.6.1 Quidel Company Details

      • 14.6.2 Quidel Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Quidel Rapid Diagnostic Testing for Influenza Product and Service

    • 14.7 Response Biomedical

      • 14.7.1 Response Biomedical Company Details

      • 14.7.2 Response Biomedical Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Response Biomedical Rapid Diagnostic Testing for Influenza Product and Service

    • 14.8 Meridian Bioscience

      • 14.8.1 Meridian Bioscience Company Details

      • 14.8.2 Meridian Bioscience Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Product and Service

    • 14.9 Thermo Fisher Scientific

      • 14.9.1 Thermo Fisher Scientific Company Details

      • 14.9.2 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product and Service

    • 14.10 SA Scientific

      • 14.10.1 SA Scientific Company Details

      • 14.10.2 SA Scientific Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 SA Scientific Rapid Diagnostic Testing for Influenza Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Rapid Diagnostic Testing for Influenza

    • Figure Rapid Diagnostic Testing for Influenza Picture

    • Table Global Rapid Diagnostic Testing for Influenza Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Rapid Diagnostic Testing for Influenza Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Rapid Diagnostic Testing for Influenza Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Rapid Diagnostic Testing for Influenza Consumption by Country (2017-2022)

    • Figure United States Rapid Diagnostic Testing for Influenza Consumption and Growth Rate (2017-2022)

    • Table Europe Rapid Diagnostic Testing for Influenza Consumption and Growth Rate (2017-2022)

    • Figure China Rapid Diagnostic Testing for Influenza Consumption and Growth Rate (2017-2022)

    • Figure Japan Rapid Diagnostic Testing for Influenza Consumption and Growth Rate (2017-2022)

    • Figure India Rapid Diagnostic Testing for Influenza Consumption and Growth Rate (2017-2022)

    • Figure South Korea Rapid Diagnostic Testing for Influenza Consumption and Growth Rate (2017-2022)

    • Figure Global Rapid Diagnostic Testing for Influenza Consumption Forecast by Country (2022-2028)

    • Figure United States Rapid Diagnostic Testing for Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Rapid Diagnostic Testing for Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Rapid Diagnostic Testing for Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Rapid Diagnostic Testing for Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Rapid Diagnostic Testing for Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Rapid Diagnostic Testing for Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type A Flu Consumption and Growth Rate (2017-2022)

    • Figure Global Type B Flu Consumption and Growth Rate (2017-2022)

    • Figure Global Point-of-care Testing Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Type A Flu Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type B Flu Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Point-of-care Testing Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Rapid Diagnostic Testing for Influenza Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Rapid Diagnostic Testing for Influenza Export by Region (Top 5 Countries) (2017-2028)

    • Table BD (Foundation Year, Company Profile and etc.)

    • Table BD Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

    • Table BD Rapid Diagnostic Testing for Influenza Product and Service

    • Table BioMerieux (Foundation Year, Company Profile and etc.)

    • Table BioMerieux Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMerieux Rapid Diagnostic Testing for Influenza Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Rapid Diagnostic Testing for Influenza Product and Service

    • Table Sekisui Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product and Service

    • Table Princeton BioMeditech Corporation (Foundation Year, Company Profile and etc.)

    • Table Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

    • Table Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product and Service

    • Table Quidel (Foundation Year, Company Profile and etc.)

    • Table Quidel Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quidel Rapid Diagnostic Testing for Influenza Product and Service

    • Table Response Biomedical (Foundation Year, Company Profile and etc.)

    • Table Response Biomedical Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

    • Table Response Biomedical Rapid Diagnostic Testing for Influenza Product and Service

    • Table Meridian Bioscience (Foundation Year, Company Profile and etc.)

    • Table Meridian Bioscience Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

    • Table Meridian Bioscience Rapid Diagnostic Testing for Influenza Product and Service

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product and Service

    • Table SA Scientific (Foundation Year, Company Profile and etc.)

    • Table SA Scientific Rapid Diagnostic Testing for Influenza Sales, Price, Value and Gross Profit (2017-2022)

    • Table SA Scientific Rapid Diagnostic Testing for Influenza Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US